Clinical Validity of Serum Antibodies to SARS-CoV-2

Study (n=115) found antibodies to SARS-CoV-2 demonstrate infection when measured ≥14 days after symptom onset, is linked to clinical severity & provide diagnostic support in patients who test negative by nucleic acid amplification but remain clinically suspicious for COVID-19

Source:

Annals of Internal Medicine